Quick Answer
Perspective Therapeutics, Inc. reported Total Assets of $266.97 million for the year ending 2025.
- Perspective Therapeutics, Inc. showed a decrease of -21.7% in Total Assets from 2024 to 2025.
- This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $7.89 million | Q4 2011: $8.45 million | Q1 2012: $7.59 million | Q3 2012: $9.66 million | Q4 2012: $8.72 million | Q1 2013: $7.89 million | Q3 2013: $9.33 million | Q4 2013: $8.19 million | Q1 2014: $27.20 million | Q3 2014: $25.54 million | Q4 2014: $24.59 million | Q1 2015: $23.58 million | Q2 2015: $23.00 million | Q3 2015: $21.91 million | Q4 2015: $20.74 million | Q1 2016: $19.80 million | Q3 2016: $16.69 million | Q4 2016: $14.99 million | Q1 2017: $13.94 million | Q3 2017: $10.78 million | Q4 2017: $9.38 million | Q1 2018: $8.32 million | Q3 2018: $13.34 million | Q4 2018: $11.91 million | Q1 2019: $10.58 million | Q3 2019: $10.12 million | Q4 2019: $8.93 million | Q1 2020: $8.96 million | Q3 2020: $8.03 million | Q4 2020: $15.51 million | Q1 2021: $71.28 million | Q3 2021: $68.71 million | Q4 2021: $67.25 million | Q1 2022: $66.11 million | Q2 2022: $64.44 million | Q3 2022: $62.54 million | Q1 2023: $127.65 million | Q2 2023: $120.15 million | Q3 2023: $110.52 million | Q1 2024: $278.29 million | Q2 2024: $385.92 million | Q3 2024: $391.15 million | Q1 2025: $329.35 million | Q2 2025: $310.73 million | Q3 2025: $294.83 million.
- Over the full 15 years of available data (2012 to 2025), Perspective Therapeutics, Inc.'s Total Assets has grown by 3,457.0%.
- Historical annual values: Fiscal year 2025: $266.97 million | Fiscal year 2024: $341.10 million | Fiscal year 2023: $97.89 million | Fiscal year 2022: $58.09 million | Fiscal year 2022: $64.44 million | Fiscal year 2021: $70.42 million | Fiscal year 2020: $8.70 million | Fiscal year 2019: $9.42 million | Fiscal year 2018: $7.46 million | Fiscal year 2017: $12.27 million | Fiscal year 2016: $18.10 million | Fiscal year 2015: $23.00 million | Fiscal year 2014: $26.55 million | Fiscal year 2013: $7.06 million | Fiscal year 2012: $7.51 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: